These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 9171752

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Thrombolysis with tissue-plasminogen activator: results with a high-dose transthrombus technique.
    Ward AS, Andaz SK, Bygrave S.
    J Vasc Surg; 1994 Mar; 19(3):503-8. PubMed ID: 8126864
    [Abstract] [Full Text] [Related]

  • 44. Long-term outcomes of low-dose catheter-directed thrombolytic therapy: a 5-year single-center experience.
    Sebastian AJ, Robinson GJ, Dyet JF, Ettles DF.
    J Vasc Interv Radiol; 2010 Jul; 21(7):1004-10. PubMed ID: 20570176
    [Abstract] [Full Text] [Related]

  • 45. Experience with pulse-spray technique in peripheral thrombolysis.
    Yusuf SW, Whitaker SC, Gregson RH, Wenham PW, Hopkinson BR, Makin GS.
    Eur J Vasc Surg; 1994 May; 8(3):270-5. PubMed ID: 8013676
    [Abstract] [Full Text] [Related]

  • 46. Accelerated thrombolysis using pulsed intra-thrombus recombinant human tissue type plasminogen activator (rt-PA).
    Buckenham TM, George CD, Chester JF, Taylor RS, Dormandy JA.
    Eur J Vasc Surg; 1992 May; 6(3):237-40. PubMed ID: 1592125
    [Abstract] [Full Text] [Related]

  • 47. Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experience.
    Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MH, Khan MA, Fail PS, Stagg SJ, Chaisson GA, Vitrella DA, Allie SD, Allie AA, Mitran EV, Walker CM.
    J Endovasc Ther; 2004 Aug; 11(4):427-35. PubMed ID: 15298512
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Infusion techniques for peripheral arterial thrombolysis.
    Kessel DO, Berridge DC, Robertson I.
    Cochrane Database Syst Rev; 2004 Aug; (1):CD000985. PubMed ID: 14973961
    [Abstract] [Full Text] [Related]

  • 50. A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction.
    Continuous Infusion versus Double-Bolus Administration of Alteplase (COBALT) Investigators.
    N Engl J Med; 1997 Oct 16; 337(16):1124-30. PubMed ID: 9340504
    [Abstract] [Full Text] [Related]

  • 51. Optimal thrombolytic strategies for acute myocardial infarction--bolus administration.
    McMechan SR, Adgey AA.
    QJM; 1998 Nov 16; 91(11):719-25. PubMed ID: 10024933
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. The influence of bolus to infusion delays on plasma Tissue Plasminogen Activator levels.
    Smith C, Al-Nuaimi Y, Wainwright J, Sherrington C, Singh A, Kallingal J, Douglass C, Parry-Jones A, Smith C, Dixit A, Majid A.
    Int J Stroke; 2014 Oct 16; 9(7):939-42. PubMed ID: 23205632
    [Abstract] [Full Text] [Related]

  • 54. [Thrombolytic therapy in acute lower extremity ischemia].
    Rørdam P, Enevoldsen MT, Grønvall Rasmussen JB, Laursen NO, Hensler MK, Madsen PV, Schroeder TV.
    Ugeskr Laeger; 1996 Sep 02; 158(36):5018-21. PubMed ID: 8928240
    [Abstract] [Full Text] [Related]

  • 55. Safety of thrombolytic therapy with urokinase or recombinant tissue plasminogen activator for peripheral arterial occlusion: a comprehensive compilation of published work.
    Ouriel K, Kandarpa K.
    J Endovasc Ther; 2004 Aug 02; 11(4):436-46. PubMed ID: 15298504
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Augmented experimental pulse-spray thrombolysis with tissue plasminogen activator, enabling dose reduction by one or more orders of magnitude.
    Bookstein JJ, Bookstein FL.
    J Vasc Interv Radiol; 2000 Mar 02; 11(3):299-303. PubMed ID: 10735423
    [Abstract] [Full Text] [Related]

  • 60. Tenecteplase in acute lower-leg ischemia: efficacy, dose, and adverse events.
    Hull JE, Hull MK, Urso JA, Park HA.
    J Vasc Interv Radiol; 2006 Apr 02; 17(4):629-36. PubMed ID: 16614145
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.